A view into 2015: Growth in the global economy to continue
Chief analyst in Danske Invest, Bo Bejstrup Christensen, takes you on a world tour presenting his view of the macroeconomic potential in 2015.
New investment opportunities
Danske Invest is expanding its product range by launching a number of new funds.
Attractive stocks for the cautious optimist
High yield stocks represent an attractive investment without too much exposure during a potential recovery for European equities. The trick is to pick the right stocks.
Households benefit from cheaper oil
The price of a barrel of crude oil has dropped by more than 25% since its peak and is now at a post-2010 low. This is good news for private households and should lift consumer spending and, by extension, spur economic growth, according to Danske Invest’s chief analyst.
Defy the trend: go for Europe
The expectations in respect of the European economy are very low, and the European central bank, the ECB, struggles to fight off deflation. However, Danske Invest's macroeconomic analyst takes an optimistic view arguing that the economy has bottomed out and that 2015 will offer some progress.
ECB brings good tidings to European business community
Last week, the European Central Bank (ECB) announced that interest rates would remain at the current all-time low and that it is prepared to spend up to EUR 1 trillion on purchasing bonds and pumping liquidity into eurozone banks.
Investing in China
Having had his reservations about China for some time, Danske Invest's chief analyst, Bo Bejstrup Christensen now takes a more upbeat view on investing in the country. However, caution is crucial when investing in China, he says.
Chief analyst: Equity markets will recover
Headlines dominated by recent slump in global equity markets, but Danske Invest’s chief analyst believes that the outlook is for markets to recover.
Three things to keep an eye on
Three things are on the agenda in the next month that could send markets up or down. Read on to see what you should look out for.
Investors rewarded by European dividend-paying stocks
European dividend-paying stocks have yielded returns significantly higher than the benchmark in 2014.
Pharmaceutical industry in aggressive pursuit of golden drugs
With patent expiries and tonnes of generic drugs, the pharmaceutical industry is compelled to develop new drugs that significantly outstrip the second best on the market.
US economy stronger than expected
Expectations for the US economy have been nudged up by improvements anticipated in the housing market and easier access to home loans.